N

Nektar Therapeutics
D

NKTR

0.94040
USD
-0.07
(-6.89%)
مغلق
حجم التداول
60,271
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
173,464,570
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    -7.11
    (-2.67%)
    258.81 USD
    AZN
    AZN
    -2.545
    (-3.79%)
    64.640 USD
    BIIB
    BIIB
    -3.790
    (-2.52%)
    146.820 USD
    BMY
    BMY
    -0.830
    (-1.44%)
    56.830 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    I
    INCY
    -1.820
    (-2.62%)
    67.550 USD
    LLY
    LLY
    -13.61
    (-1.75%)
    764.69 USD
    MRK
    MRK
    -1.770
    (-1.77%)
    98.300 USD
    PFE
    PFE
    -0.560
    (-2.12%)
    25.870 USD
    REGN
    REGN
    -25.38
    (-3.43%)
    714.50 USD
    المزيد
الأخبار

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).